Drug Infusion Systems Market Report on the Untapped Growth Opportunities in the Industry

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Drug Infusion Systems Market- by Product (Large Volume Infusion Systems, Patient-Controlled Analgesia, Elastomeric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Systems, Implantable Infusion Systems, Ambulatory Infusion Systems and Enteral Infusion Systems), Application (Oncology/Chemotherapy, Diabetes, Analgesia, Nutrition, Haematology, Paediatrics and Other Applications), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the global  Drug Infusion Systems Market Size is valued at 12.35 Billion in 2023 and is predicted to reach 24.04 Billion by the year 2031 at an 8.90% CAGR during the forecast period for 2024-2031.

Request For Free Sample Pages:

https://www.insightaceanalytic.com/request-sample/1271

A patient’s circulatory system can be infused with fluids, nutrients, or medications using an infusion system, which is a pump. Although occasionally used for epidural and arterial infusions, it is typically administered intravenously, and it is typically employed to manage or treat conditions affecting the nervous system. Drug infusion systems are employed in a range of pharmacological therapies to control the intravenous or non-oral administration of pharmaceuticals such as antibiotics, chemotherapeutic agents, insulin, and opioids.

The rapidly rising demand for safe and accurate drug delivery systems and the increasing frequency of chronic diseases and disorders in countries throughout the world are likely to drive revenue growth in the global drug infusion systems market. A drug infusion system capable of providing a fluid medicine, including a number of drugs, to the patient under the sustenance of a healthcare expert. These systems are used to provide a specific dosage of a medicine, and the technology calculates the resulting medicine dosage and displays it to the physician. 

North America is anticipated to be the major contributor to the Drug Infusion Systems market over the forecast years because chronic disease prevalence is increasing in countries such as the United States and Canada Furthermore, the increasing number of procedures conducted in hospitals is likely to fuel regional market expansion. In addition, the Asia Pacific Drug Infusion Systems market is expected to grow significantly during the forecast period due to the rising frequency of diabetes and cancer in the region’s countries. 

Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1271

Major market players operating in the Drug Infusion Systems market include

Acromed AG, B. Braun Melsungen AG, Becton, Dickinson and Company, Baxter International Inc., Caesarea Medical Electronics Ltd., Flowonix Medical Inc., Fresenius SE & Co. KGaA, Debiotech S.A., Halyard Health, Inc., IRADIMED CORPORATION, Insulet Corporation, Medtronic, ICU Medical Inc., MOOG, Inc., Smiths Group plc, Tandem Diabetes Care, Inc., Terumo Corporation and Zyno Medical, LLC among others.

Recent collaborations and agreements in the market:

  • In August 2021, Smiths Medical and Ivenix announced a collaboration on best-in-class infusion management technology to improve the infusion administration process.
  • In July 2021, Innovative Health Sciences announced the CE mark for a syringe infusion system.
  • In May 2020,International Baxter Inc. The Evo IQ Infusion System has acquired CE certification and regulatory approval from Australia’s Therapeutic Goods Administration, according to Baxter International Inc., a global pioneer in advanced drug delivery technology (TGA). With the release of the Evo IQ Infusion System, there is now a wider range of infusion therapy options for different types of patients.
  • In January 2020, Medtronic (Ireland) released Efficio, a cloud-based data management software designed to work with the SynchroMed II intrathecal medication delivery system. This allows clinicians to manage their targeted medication delivery pump procedures more efficiently while treating patients with chronic pain, cancer, and severe spasticity.

Get Specific Chapter/Information From The Report:@

https://www.insightaceanalytic.com/customisation/1271

Market Segments

Global Drug Infusion Systems Market, by Product Type, 2024-2031 (Value US$ Mn)

  • Large Volume Infusion Systems
  • Patient-Controlled Analgesia
  • Elastomeric Infusion Pumps
  • Insulin Infusion Pumps
  • Syringe Infusion Systems
  • Implantable Infusion Systems
  • Ambulatory Infusion Systems
  • Enteral Infusion Systems

Global Drug Infusion Systems Market, by Application, 2024-2031 (Value US$ Mn)

  • Oncology/Chemotherapy
  • Diabetes
  • Analgesia
  • Nutrition
  • Haematology
  • Paediatrics
  • Other Applications

Global Drug Infusion Systems Market, by Region, 2024-2031 (Value US$ Mn)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Drug Infusion Systems Market, by Country, 2024-2031 (Value US$ Mn)

  • S.
  • Canada

Europe Drug Infusion Systems Market, by Country, 2024-2031 (Value US$ Mn)

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Drug Infusion Systems Market, by Country, 2024-2031 (Value US$ Mn)

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Drug Infusion Systems Market, by Country, 2024-2031 (Value US$ Mn)

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Drug Infusion Systems Market, by Country, 2024-2031 (Value US$ Mn)

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Get More Information :

https://www.insightaceanalytic.com/report/global-drug-infusion-systems-market/1271

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.

Contact Us:

info@insightaceanalytic.com

InsightAce Analytic Pvt. Ltd.

Visit: www.insightaceanalytic.com

Tel : +1 607 400-7072

Asia: +91 79 72967118

Follow Us on LinkedIn @ bit.ly/2tBXsgS

Follow Us On Facebook @ bit.ly/2H9jnDZ

Twitter: https://twitter.com/Insightace

    Written by

    Insightace Analytic

    InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and re positioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

    Leave a Comment